Filing Details
- Accession Number:
- 0001437749-23-032809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-21 20:11:35
- Reporting Period:
- 2023-11-17
- Accepted Time:
- 2023-11-21 20:11:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1285819 | Omeros Corp | OMER | Pharmaceutical Preparations (2834) | 911663741 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1472160 | Md A Gregory Demopulos | 201 Elliott Avenue West Seattle WA 98119 | Chairman, Ceo & President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-17 | 15,000 | $1.68 | 123,945 | No | 4 | P | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,026,986 | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose.